34.23 0.48 (1.42%)
3.3M XNYS Volume
XNYS 31 Mar, 2025 4:00 PM (EDT)
Baxter International Inc. Key Metrics
Select
All financials are in USD Million and price data in USD
VIEW MORE
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Check Before You Buy
VIEW FULL CHECKLISTMedium rank
9Positive12Negative
42.9% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
Baxter International Inc. Stock Price Analysis
Day Price Range | 34.2 (LTP) 33.634.5 LowHigh |
Week Price Range | 34.2 (LTP) 32.834.5 LowHigh |
Month Price Range | 34.2 (LTP) 32.837.7 LowHigh |
52 Week Price Range | 34.2 (LTP) 28.344 LowHigh |
Baxter International Inc. Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Hit
Baxter International Inc.'s Revenue was higher than average estimate 3 times in past 3 years
EPS forecast
Current EPS
Avg. Estimate
Hit
EPS is expected to grow by 190.6% in FY25
Consensus Recommendation
18 ANALYST Recommendations
HOLD
The consensus recommendation from 18 analysts for Baxter International Inc. is HOLD
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Baxter International Inc. Stock Analysis
Baxter International Inc. stock analysis with key metrics, changes, and trends.
Baxter International Inc. Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Revenue | $10,636 M | 2.66% | positive |
| |
Annual Net Profit | $649 M | 124.44% | negative |
| |
Price to Earning Ratio | -27.05 | - | negative |
| |
Stock Price | $34.23 | -19.91% | negative |
| |
Quarterly Revenue | $2,753 M | 0.99% | positive |
| |
Quarterly Net profit | $512 M | 308.98% | negative |
| |
Debt to Equity Ratio | 1.93 | - | negative |
| |
Return on Equity(ROE) | -8.45 % | -8.45% | negative |
| |
Mutual Fund Holding | 79.47 % | 0.41% | positive |
| |
Promoter Share Holding | 0.21 % | -0.01% | negative |
| |
Interest Coverage Ratio | 0.29 | - | negative |
| |
Institutional Holding | 95.14 % | 0% | neutral |
|
Loading data..
Baxter International Inc. - Company Profile
What does Baxter International Inc. do?

Baxter International Inc offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
Baxter International Inc. Management structure
All Gross Remunerations are in USD